Cell line studies have already demonstrated that angiogenic factors play a role in HMGA2‐mediated tumorigenesis, indicating therapeutic potential of angiogenesis inhibitors in HMGA2‐positive leiomyomas.59 Here, HMGA2 is linked to leiomyoma.